ABK Biomedical

Halifax, Canada · Founded 2012 · Privately Held (backing)

Developer of a microsphere product designed to improve the treatment of hypervascular tumors. ABK Biomedical is based in Halifax, Canada and was founded in 2012. Its last reported valuation was $73 million in Dec 2022. It has raised $122 million across 4 recorded rounds; the latest was a $2.6 million seed round in Oct 2025.

Last reported valuation
$73.0M
Oct 2026
Priced at
—
Total raised
$121.7M
Last round
Seed Round
Oct 2025

Who backs ABK Biomedical?

11 investors
InvestorType
F-Prime CapitalVenture capital
Eight RoadsAsset manager
Invest Nova ScotiaOther
PIC Investment GroupFamily office
Atlantic Canada Opportunities Agency—
JPMorgan Life Sciences Private Capital—
Life Sciences Nova Scotia—
MedVenture Partners (Japan)—
Santé Ventures—
Varian Medical Systems—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ABK Biomedical investors

11 investors are on record for ABK Biomedical, including F-Prime Capital, Eight Roads, Invest Nova Scotia and PIC Investment Group. The seed round in Oct 2025 drew 6 investors.

Free account
More of ABK Biomedical with a free account
  • ·The complete investor list: 11 names
  • ·Watch ABK Biomedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like ABK Biomedical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View